GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
U

Universal Vision Biotechnology Co 3218.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

124.50

-1.58%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 4.20bn

FY2016FY2025

Net income

TWD 1.04bn

FY2016FY2025

Free cash flow

TWD 1.10bn

FY2016FY2025

Shareholders' equity

TWD 4.02bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 4.20bnTWD 4.23bnTWD 4.08bnTWD 3.49bnTWD 2.63bnTWD 2.05bnTWD 1.42bnTWD 1.19bnTWD 1.08bnTWD 1.07bn
Gross profitTWD 2.48bnTWD 2.53bnTWD 2.45bnTWD 2.14bnTWD 1.64bnTWD 1.27bnTWD 817.1mTWD 647.5mTWD 587.0mTWD 591.0m
Operating incomeTWD 1.38bnTWD 1.40bnTWD 1.34bnTWD 1.11bnTWD 776.6mTWD 613.1mTWD 247.0mTWD 139.8mTWD 129.0mTWD 113.7m
Net incomeTWD 1.04bnTWD 1.06bnTWD 1.05bnTWD 850.5mTWD 595.4mTWD 483.2mTWD 238.0mTWD 161.5mTWD 120.1mTWD 91.8m
Diluted earnings per share12.3112.5612.2910.027.826.353.132.121.582.06

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 6.09bnTWD 5.76bnTWD 5.13bnTWD 4.51bnTWD 3.75bnTWD 3.17bnTWD 2.65bnTWD 2.10bnTWD 2.00bnTWD 1.74bn
Cash and short-term investments——TWD 1.64bnTWD 1.28bnTWD 1.04bnTWD 1.08bnTWD 711.1m———
Total liabilitiesTWD 1.93bnTWD 2.01bnTWD 1.79bnTWD 1.68bnTWD 1.42bnTWD 1.13bnTWD 951.8mTWD 487.9mTWD 421.6mTWD 582.9m
Debt—TWD 1.05bnTWD 778.3mTWD 783.6mTWD 767.5mTWD 614.1mTWD 582.7mTWD 152.9mTWD 100.0mTWD 240.0m
Shareholders' equityTWD 4.02bnTWD 3.62bnTWD 3.18bnTWD 2.66bnTWD 2.19bnTWD 1.91bnTWD 1.59bnTWD 1.48bnTWD 1.41bnTWD 1.16bn
Shares outstanding85m85m85m85m76m76m76m76m76m45m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 1.67bnTWD 1.67bnTWD 1.55bnTWD 1.27bnTWD 911.8mTWD 827.1mTWD 419.2mTWD 273.1mTWD 236.5mTWD 255.1m
Capital spending−TWD 563.8m−TWD 437.1m−TWD 474.3m−TWD 492.8m−TWD 328.7m−TWD 298.5m−TWD 235.2m−TWD 204.8m−TWD 134.7m−TWD 173.9m
Free cash flowTWD 1.10bnTWD 1.23bnTWD 1.08bnTWD 775.3mTWD 583.1mTWD 528.6mTWD 184.0mTWD 68.3mTWD 101.8mTWD 81.3m
Dividends paid−TWD 635.4m−TWD 593.1m−TWD 479.6m−TWD 380.6m−TWD 319.7m−TWD 152.2m−TWD 95.2m−TWD 91.3m−TWD 87.5m−TWD 72.7m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 1.13bnTWD 1.09bnTWD 1.03bnTWD 1.02bnTWD 1.02bnTWD 1.12bnTWD 1.04bnTWD 1.08bn
Gross profitTWD 650.2mTWD 625.3mTWD 607.2mTWD 604.4mTWD 604.4mTWD 666.6mTWD 610.5mTWD 630.7m
Operating incomeTWD 346.8mTWD 334.0mTWD 338.2mTWD 314.8mTWD 334.5mTWD 389.7mTWD 370.1mTWD 324.3m
Net incomeTWD 226.5mTWD 280.8mTWD 294.3mTWD 343.2mTWD 42.5mTWD 362.6mTWD 239.0mTWD 243.7m
Diluted earnings per share2.673.313.474.050.504.282.822.87
Cash from operationsTWD 398.0mTWD 537.0mTWD 521.0mTWD 319.0mTWD 242.0mTWD 583.0mTWD 485.0mTWD 425.0m
Capital spending−TWD 91.0m−TWD 57.0m−TWD 184.0m−TWD 139.0m−TWD 157.0m−TWD 82.0m−TWD 119.0m−TWD 134.0m
Free cash flowTWD 307.0mTWD 480.0mTWD 337.0mTWD 180.0mTWD 85.0mTWD 501.0mTWD 366.0mTWD 291.0m
Total assetsTWD 6.40bnTWD 6.54bnTWD 6.09bnTWD 5.94bnTWD 5.69bnTWD 6.21bnTWD 5.76bnTWD 5.83bn
Shareholders' equityTWD 3.87bnTWD 3.65bnTWD 4.02bnTWD 3.72bnTWD 3.36bnTWD 3.36bnTWD 3.62bnTWD 3.39bn

Financial ratios

Data as of 4 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2007FY2006
Gross margin72.0%72.2%60.0%61.2%62.2%61.7%————
Operating margin32.8%33.1%32.8%31.9%29.5%29.9%————
Net margin24.8%25.2%25.6%24.3%22.6%23.5%————
Return on equity25.9%29.4%32.9%31.9%27.2%25.2%————
Return on assets17.1%18.5%20.4%18.9%15.9%15.2%————
Free cash flow yield—18.6%17.9%15.5%12.2%11.1%6.4%———
Revenue growth-0.6%3.6%16.8%32.8%28.2%44.7%————
Earnings growth-2.1%1.9%22.9%42.8%23.2%103.0%————
Current ratio2.92x2.61x2.52x2.37x2.43x2.18x————
Debt to equity——0.05x0.06x0.07x0.15x0.05x0.10x——
Equity ratio66.0%62.9%61.9%59.1%58.4%60.4%————
Interest coverage55.43x66.85x84.56x82.08x59.00x56.04x————
R&D as a share of sales————————0.2%0.4%
Buybacks as a share of market value—0.3%-0.1%-11.6%0.0%0.0%————

Growth per year

Compound annual rate

3 years5 years10 years
Revenue6.4%15.4%15.3%
Operating income7.3%17.6%31.1%
Net income7.0%16.6%29.1%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin59.5%60.0%60.4%59.4%
Operating margin32.9%32.7%32.0%27.7%
Net margin25.0%25.0%24.6%21.8%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings11.915.922.528.132.533.819.410.715.19.7
Price to sales2.94.05.86.87.38.03.31.41.70.8

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 26 Mar 2026.

FY2026FY2025FY2024FY2023FY2022
Paid in the year7.757.507.006.004.492
  • 1060-for-1000 split · 25 Aug 2023
  • 1050-for-1000 split · 26 Aug 2022

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.